New York City-based Mount Sinai Health System has opened a $23 million center where clinicians, engineers and medical device companies will develop and test surgical technologies, according to a Nov. 19 news release.
The Comprehensive Center for Surgical Innovation spans three facilities at The Mount Sinai Hospital and supports devices from early prototypes through preparation for human clinical trials:
- A medical device incubator lab with 3D printers, used for design, prototyping and preparing devices for FDA review
- A surgical innovation center and human anatomy lab with robotic surgical suites, bench-top testing and cadaver-based validation
- A preclinical large-animal research facility with an angiography suite that serves as an OR for testing endovascular devices and surgical systems
An $11.6 million grant from the New York City Economic Development Corporation helped fund the center. Other funding came from Mount Sinai’s neurosurgery department, ventures launched through Mount Sinai BioDesign and donors. The center expands Mount Sinai BioDesign, a medtech incubator the neurosurgery department launched in 2014. BioDesign is testing more than 15 innovation concepts across more than 10 areas of healthcare.
